Democrats say Trump increased investments in drugmakers that benefited from Medicare exemptions

Summary

Democrats say President Donald Trump increased investments in drugmakers that benefited from Medicare exemptions, The Philadelphia Inquirer reported on Friday 16 October, Trump's investments in pharmaceutical companies having significantly increased after Trump's return to the White House. A report released on Friday by the Joint Economic Committee's minority arm found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025, the LA Times reported. Fortune reported the same figures and said the White House denies conflicts.

Latest: A report by the Joint Economic Committee's minority arm found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025, as drugmakers gained Medicare exemptions, the LA Times and Fortune reported, the White House denying conflicts according to Fortune.

Written automatically by an AI from the articles' headlines and descriptions. It can contain errors: follow the links to read the articles.